NANOG and breast cancer: Recently, our preliminary data indicate both Stat-3/Nanog and JNK/c-Jun pathways can be simultaneously activated in the upregulation of miR-21 expression during HA/CD44-mediated signaling in both breast cancer cells and head and neck cancer cells.